Meeting
2024 ASCO Genitourinary Cancers Symposium
Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Two-year quality of life and toxicity outcomes of a multicenter phase II trial.
Authors
John Nikitas
Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA
John Nikitas , Leslie K. Ballas , Antonio Franco , Connor Lynch , Ting Martin Ma , Luca Faustino Valle , Tahmineh Romero , Ankush Sachdeva , Natalie Chong , Vincent Basehart , Robert Evan Reiter , Christopher Saigal , Karim Chamie , Mark S. Litwin , Matthew Rettig , Nicholas George Nickols , Michael L. Steinberg , Minsong Cao , Stanley L. Liauw , Amar Upadhyaya Kishan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Clinical Trial Registration Number
NCT03541850
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 317)
DOI
10.1200/JCO.2024.42.4_suppl.317
Abstract #
317
Poster Bd #
N8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.
First Author: Wee Loon Ong
Poster
2020 ASCO Virtual Scientific Program
A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).
First Author: Francis W. Nugent III
Poster
2017 Genitourinary Cancers Symposium
The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
First Author: Stephane Gilles Guerif
Poster
2017 Gastrointestinal Cancers Symposium
A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).
First Author: Francis W. Nugent III